Real‐Time Imaging Guided MTH1 Inhibition‐Augmented Ferroptosis Therapy by Engineered Nanoinducers
Small · 2026-11 · 22 (62)
DOI: 10.1002/smll.75872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 14.10.2026. Verfasst von Shan Lei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engin…. Hauptthemen laut MEDLINE: Phosphoric Monoester Hydrolases, Ferroptosis, DNA Repair Enzymes. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Medical Research Fund.
Abstract (Originalsprache)
Conventional ferroptosis inducers often suffer from off‐target iron accumulation and insufficient reactive oxygen species (ROS) amplification in tumors, as well as a lack of imaging guidance, and their efficacy is further counteracted by MutT homolog 1 (MTH1)‐mediated sanitization of oxidative DNA damage, collectively limiting therapeutic precision. Here, to circumvent these barriers, we report an engineered nanoinducer integrating ferric ions and a phosphonate‐containing hemi‐cyanine scaffold for real‐time imaging‐guided, MTH1 inhibition‐augmented ferroptosis. This nanoinducer exhibits tumor‐specific accumulation and acid‐triggered dissociation, releasing ferric ions (ferroptosis inducer) and the MTH1 inhibitor TH588. The release kinetics are visualized in real‐time via fluorescence imaging using a phosphatase‐cleavable hemi‐cyanine probe, enabling dynamic therapy monitoring. Mechanistically, ferric ions generate hydroxyl radicals to drive lipid peroxidation and nucleotide oxidation, inducing ferroptosis and DNA mispairing, while TH588 suppresses MTH1 activity, blocking ROS‐induced DNA damage repair and amplifying ROS cytotoxicity. This synergistic strategy significantly enhances antitumor efficacy, suppresses metastasis, and exhibits minimal off‐target toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenz…
- College of Materials Science and Engineering, Shenzhen University, Shenzhen, People's Republic of China.
ORCID-Profile: Shan Lei, Yurong Liu, Peng Huang, Jing Lin
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Medical Research Fund
- Shenzhen Science and Technology Program
- Research Team Cultivation Program of Shenzhen University
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Lei, S., Sun, W., Huang, T., Chen, K., Li, M., Liu, Q., Guo, H., Liu, Y., Huang, P., & Lin, J. (2026). Real‐Time Imaging Guided MTH1 Inhibition‐Augmented Ferroptosis Therapy by Engineered Nanoinducers. Small, 22(62). https://doi.org/10.1002/smll.75872
Vancouver
Lei S, Sun W, Huang T, Chen K, Li M, Liu Q, et al. Real‐Time Imaging Guided MTH1 Inhibition‐Augmented Ferroptosis Therapy by Engineered Nanoinducers. Small. 2026;22(62). doi:10.1002/smll.75872
BibTeX
@article{Lei2026,
author = {Lei, Shan and Sun, Wei and Huang, Ting and Chen, Kaiwei and Li, Meng and Liu, Qiang and Guo, Huishan and Liu, Yurong and Huang, Peng and Lin, Jing},
title = {Real‐Time Imaging Guided MTH1 Inhibition‐Augmented Ferroptosis Therapy by Engineered Nanoinducers},
journal = {Small},
year = {2026},
volume = {22},
number = {62},
doi = {10.1002/smll.75872}
}
EUVIMED